| Full text | |
| Author(s): |
Ferracini, A. C.
[1]
;
Rodrigues, A. T.
[1]
;
de Barros, A. A.
[2]
;
Derchain, S. F.
[3]
;
Mazzola, P. G.
[4]
Total Authors: 5
|
| Affiliation: | [1] Univ Estadual Campinas, Fac Med Sci, Grad Program Med Sci, Campinas, SP - Brazil
[2] Univ Estadual Campinas, Pharm Serv Womens Hosp CAISM, Campinas, SP - Brazil
[3] Univ Estadual Campinas, Dept Obstet & Gynecol, Fac Med Sci, Campinas, SP - Brazil
[4] Univ Estadual Campinas, Fac Pharmaceut Sci, Campinas, SP - Brazil
Total Affiliations: 4
|
| Document type: | Journal article |
| Source: | EUROPEAN JOURNAL OF CANCER CARE; v. 27, n. 1 JAN 2018. |
| Web of Science Citations: | 3 |
| Abstract | |
Oncologic inpatients often require multiple drug therapy. They may be at higher risk of experiencing prescribing errors, which pharmacist interventions may help to avoid. This study aimed to evaluate the types of prescribing errors, pharmaceutical interventions and differences in clinical significance, in prescriptions for hospitalised patients with breast and gynaecological cancer. A cross-sectional, prospective study was conducted at the oncology ward of a clinic specialised in breast and gynaecology cancer. A clinical pharmacist analysed prescriptions, identified errors, performed interventions and classified clinical significance. A total of 1,874 prescriptions of 248 patients were evaluated; 11.5% prescriptions were involved at least in one prescribing error, totalising 283 errors. The most common error was unsafe medication due to drug interaction (89{[}31.4%]). Drugs for the alimentary tract and metabolism, and nervous system were the most involved in errors with statistical association (p=.0246 and p=.0002 respectively). Of the 294 interventions, 73.5% were accepted. The clinical significance of prescribing errors and interventions were classified as significant and very significant respectively. The pharmacist interventions obtained a good acceptance rate and impact significantly, avoiding prescribing errors classified as significant. (AU) | |
| FAPESP's process: | 14/04226-6 - Safety in medication use in an oncology unit of a hospital specialized in women's health |
| Grantee: | Amanda Canato Ferracini |
| Support Opportunities: | Scholarships in Brazil - Master |